Omega Healthcare Investors Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 70.7% | 68.9% | 62.6% | 72.8% | 67.6% | 81.3% | 66.2% | 84.7% | 72.8% | 71.7% | 67.8% | 63.9% | 68.9% | |
| 33.4% | 31.6% | 30.6% | 29.4% | 28.0% | 28.1% | 28.9% | 28.5% | 26.4% | 25.7% | 26.1% | 24.4% | 25.6% | |
| 3.6% | 3.7% | 3.8% | 3.6% | 3.3% | 3.3% | 5.7% | 3.3% | 3.0% | 3.1% | 3.3% | 7.0% | 4.1% | |
| -1.5% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.4% | 3.8% | -3.8% | 4.1% | 0.6% | 10.8% | -6.7% | 6.7% | 0.5% | -1.5% | -5.7% | 5.5% | -0.3% | |
| 4.2% | 6.1% | 2.9% | 2.8% | 3.0% | 5.5% | 7.3% | 4.5% | 4.1% | 222.7% | 2.7% | 2.6% | 57.8% | |
| 30.0% | 46.5% | -19.9% | -82.5% | -48.3% | -100.2% | 6.5% | -164.1% | -26.9% | -3.6% | -84.7% | 165.5% | 14.4% | |
| 68.0% | 68.8% | 67.7% | 65.7% | 62.8% | 65.0% | 68.4% | 68.9% | 63.6% | 61.6% | 61.4% | 59.6% | 61.5% | |
| 0.0% | -178.4% | – | – | 290.3% | 442.4% | 94.2% | 183.3% | -0.7% | 188.5% | -4.1% | 4.0% | 46.8% | |
| 2.4% | – | – | – | -26.6% | -0.9% | -144.7% | 192.6% | -0.4% | -226.0% | 56.7% | -124.8% | -74.7% | |
| -17.3% | -162.9% | -76.5% | -118.4% | 97.1% | 87.1% | -125.6% | 208.5% | -44.6% | -292.2% | 16.8% | -190.4% | -128.8% | |
| 83.2% | -47.3% | -33.6% | -128.2% | 116.4% | 67.5% | -52.3% | 130.4% | 0.8% | -223.9% | -0.4% | 39.0% | -45.5% | |
| 66.5% | 62.8% | 59.8% | 70.2% | 64.6% | 75.8% | 58.9% | 80.3% | 76.9% | 71.7% | 65.1% | 66.5% | 69.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.